Gourt > Health > Pharmacy > Drugs and Medications > S > Sumatriptan
Sumatriptan (Imitrex, Imigran,Imigran Recovery ) is a triptan drug including a sulfonamide group which was originally developed by Glaxo for the treatment of migraine headaches.
Approval and availability
Several dosage forms for sumatriptan have been approved, including tablets, solution for injection, and nasal inhalers. Sumatriptan was the first triptan available (in 1991), and, in the United States and most developed countries, is available only by medical prescription. In the United Kingdom, sumatriptan is available over the counter, under the name of Imigran Recovery. It is sold in packs of two 50mg tablets for approximately £7.99. Larger pack sizes, the nasal spray, and the liquid preparation for injection are still only available by prescription.
Mode of action
Sumatriptan is a 5-HT (5-HT1D) agonist. The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve. More on [ Sumatriptan ]
DrugDigest: Sumatriptan ( Imitrex ) - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.
Imitrex - Product information from Glaxo Wellcome, in Portable Document Format (PDF). (sumatriptan succinate)
Meta Description: [ This site serves as the homepage of GSK's corporate web site. ]
404
Imitrex - Product information for US residents in PDF format. [Acrobat Reader required]
Meta Description: [ About GSK summarizes the mission of GSK and provides users with an overview of the organization and biographies of our Board of Directors and Corporate Executive Team. ]
| Nostril Errors with Nasal Sprays (Oct. 2006) | |
